How Much Does Tirosint Cost in Minnesota in 2026?

Minnesota Retail Pricing for Tirosint

The average cash price for a 30-day Tirosint supply across Minnesota retail pharmacies sits at roughly $230 in 2026. That figure holds whether you fill at a chain like CVS, Walgreens, or a local independent. The price does not vary much by dose strength because IBSA uses flat pricing across its capsule range (13 mcg through 200 mcg).

Why does Tirosint cost more than standard levothyroxine tablets? The gel capsule formulation contains only four ingredients: levothyroxine sodium, gelatin, glycerin, and water. No dyes, no lactose, no gluten. This matters clinically. A 2014 study by Vita et al. showed that patients with lactose intolerance, celiac disease, or documented malabsorption who were switched from levothyroxine tablets to the gel capsule formulation achieved significantly improved TSH normalization without dose adjustment 1. The FDA-approved labeling for Tirosint confirms the same active ingredient (levothyroxine sodium) as standard tablets but in a formulation designed to reduce excipient-related absorption variability.

Standard levothyroxine tablets (Synthroid, Levoxyl, generics) cost $4-$30 per month at most Minnesota pharmacies. The roughly 8-to-57-fold price gap between generic tablets and Tirosint reflects the specialty formulation, patent protection, and the absence of an AB-rated generic gel capsule competitor. For patients who absorb standard tablets without issue, the tablet remains the cost-effective choice. For patients with documented malabsorption, the gel capsule addresses a real clinical problem.

Prices can shift by $10-$40 depending on the specific pharmacy. Costco and independent pharmacies in the Minneapolis-St. Paul metro area tend to price slightly lower than national chains, though the difference rarely exceeds 15%.

Minnesota Medicaid Coverage

Minnesota Medicaid (Medical Assistance) covers Tirosint, but requires prior authorization. This means your prescriber must document clinical need before the state will pay.

The PA process typically requires documentation of one or more of the following: treatment failure on at least one standard levothyroxine tablet, diagnosed malabsorption condition (celiac disease, inflammatory bowel disease, gastric bypass history, lactose intolerance affecting absorption), or persistent TSH instability despite confirmed adherence to standard tablets. The American Thyroid Association's 2014 guidelines for the treatment of hypothyroidism note that liquid or gel capsule formulations may be considered for patients with known absorption difficulties or those taking medications that interfere with levothyroxine tablet absorption, such as proton pump inhibitors or calcium supplements taken concurrently 2.

Minnesota's Department of Human Services reviews Tirosint PAs through its Preferred Drug List (PDL) process. Approval turnaround averages 24-72 hours. If denied, you have the right to a fair hearing appeal under Minnesota Statute 256B.0625.

For MinnesotaCare enrollees (the state's insurance program for residents who earn too much for Medicaid but cannot afford private coverage), the same PA pathway applies. Copays under MinnesotaCare for brand-name drugs range from $3 to $25 per fill depending on income tier.

Commercial Insurance Coverage in Minnesota

Most major commercial insurers in Minnesota place Tirosint on Tier 3 (preferred brand) or Tier 4 (non-preferred brand) of their formularies. Coverage varies by plan, and some require step therapy through generic levothyroxine tablets first.

Blue Cross Blue Shield of Minnesota lists Tirosint on its standard formulary with prior authorization for most employer-sponsored plans. The typical Tier 3 copay runs $40-$75 per fill. Medica, another major Minnesota carrier, follows a similar structure: PA required, Tier 3 placement, copays in the $35-$60 range for most HMO and PPO products.

HealthPartners, headquartered in Bloomington, generally requires step therapy. You must trial and document inadequate response to at least one generic levothyroxine product before Tirosint is approved. Once approved, copays typically land between $40 and $65.

UCare and Hennepin Health plans (serving Hennepin County's Medicaid and dual-eligible populations) follow the state Medicaid PA criteria described above.

For patients on Medicare Part D in Minnesota, Tirosint coverage depends entirely on the specific Part D plan. During the coverage gap (the "donut hole"), patients paid no more than 25% of the negotiated price for brand-name drugs in 2025, and the Inflation Reduction Act's $2,000 annual out-of-pocket cap (fully effective as of 2025) means that Tirosint's cost is capped once you hit that threshold 3. The $2,000 cap applies regardless of how many prescriptions contribute to reaching it.

The IBSA Savings Card

IBSA, the manufacturer, offers a patient savings card that can reduce Tirosint copays for commercially insured patients. The program is sometimes called the "Tirosint Co-Pay Card" or "IBSA Savings Program."

How it works: you present the card at any participating Minnesota pharmacy alongside your insurance card. The card covers a portion of your copay, potentially reducing your cost to $0-$25 per fill. The savings card cannot be used with government insurance (Medicaid, Medicare, Tricare, VA). It can be used with commercial plans, including employer-sponsored and ACA marketplace plans.

Enrollment is free and available online at the manufacturer's website or through your prescriber's office. The card is typically valid for 12 fills per calendar year. Some versions cap the per-fill benefit at $100-$150 in manufacturer-paid assistance, which means it works best for patients whose copay falls below that threshold.

One important limitation: if your plan does not cover Tirosint at all (full cash price), the savings card usually does not apply. It is designed to offset copays, not replace insurance coverage entirely.

Compounded Levothyroxine in Minnesota

Licensed 503A compounding pharmacies in Minnesota can legally prepare levothyroxine in capsule or liquid form with a valid patient-specific prescription. This is not a gray area. Federal law under the Drug Quality and Security Act (DQSA) of 2013 permits 503A pharmacies to compound medications, including levothyroxine, when a prescriber determines that a commercially available product does not meet a patient's medical needs 4.

The Minnesota Board of Pharmacy regulates 503A compounding within the state. Compounding pharmacies must hold a valid Minnesota pharmacy license and comply with USP <795> standards for non-sterile compounding.

Cost is where it gets interesting. Compounded levothyroxine capsules from a 503A pharmacy in Minnesota typically run $30-$60 per month, a significant reduction from Tirosint's $230 cash price. Some compounding pharmacies charge even less for straightforward formulations.

The tradeoff: compounded levothyroxine is not FDA-approved and does not undergo the same bioequivalence testing as manufactured products. Potency can vary between batches. The American Thyroid Association has noted that compounded thyroid preparations lack the standardized quality controls of FDA-approved products and recommends them only when no suitable FDA-approved alternative exists 2. If your reason for avoiding standard tablets is excipient sensitivity (lactose, dyes, gluten), a compounding pharmacy can formulate a capsule without those specific excipients while using a hypoallergenic base.

Several 503A pharmacies in the Twin Cities metro operate compounding labs that prepare levothyroxine formulations. Patients in Greater Minnesota can often receive compounded medications by mail from these pharmacies, as Minnesota does not restrict intrastate mail-order dispensing of compounded preparations.

Telehealth Prescribing in Minnesota

Minnesota allows telehealth prescribing of Tirosint and other levothyroxine formulations without restriction. The Minnesota Board of Medical Practice has maintained telehealth-friendly policies since before the COVID-19 pandemic, and the state's telehealth parity law (Minnesota Statute 62A.672) requires insurers to cover telehealth visits at the same rate as in-person visits.

A prescriber licensed in Minnesota can evaluate your thyroid labs, review your medication history, and write a Tirosint prescription during a video or audio visit. No in-person visit is required for an initial or ongoing thyroid prescription in Minnesota. Lab orders for TSH and free T4 can be placed electronically, with draws performed at any LabCorp, Quest, or hospital outreach lab location across the state.

This opens access for patients in rural Minnesota who may not have an endocrinologist within reasonable driving distance. According to the Minnesota Department of Health, 51 of 87 Minnesota counties are classified as medically underserved or have health professional shortage area designations 5. Telehealth eliminates the geographic barrier entirely for thyroid medication management.

Discount Strategies That Actually Work

Beyond insurance and the IBSA savings card, several practical approaches can reduce Tirosint cost in Minnesota.

GoodRx and RxSaver coupons. These pharmacy discount aggregators negotiate rates with pharmacies. Tirosint prices through GoodRx in Minnesota typically range from $180-$220, saving $10-$50 off the $230 cash price. Not significant, but meaningful over 12 months.

Mark Cuban Cost Plus Drugs. As of mid-2026, Cost Plus Drugs does not stock Tirosint (it is a branded product without generic competition). However, Cost Plus does offer standard levothyroxine tablets at approximately $4-$6 for a 90-day supply, which is relevant for patients who can tolerate tablet formulations.

Patient assistance programs. IBSA does not currently operate a formal patient assistance program (PAP) for uninsured patients in the way that large pharma companies do for biologics. However, NeedyMeds and RxAssist databases list occasional charitable programs that include thyroid medications.

90-day fills. If your insurer covers Tirosint, switching from 30-day to 90-day fills (often through mail-order pharmacy) can reduce per-unit cost. Many Minnesota plans charge 2.0-2.5x the 30-day copay for a 90-day supply, effectively giving you one month free per quarter.

Therapeutic alternatives. Tirosint-SOL (levothyroxine oral solution) is a liquid formulation from the same manufacturer. It addresses the same malabsorption concerns as the gel capsule but is priced similarly. It does not offer a cost advantage, but some insurance formularies cover one and not the other, so checking both is worth the effort.

When the Gel Capsule Is Clinically Justified

Not every patient needs Tirosint. The gel capsule formulation solves a specific problem: inconsistent levothyroxine absorption due to excipient interactions or gastrointestinal conditions.

The Endocrine Society's clinical practice guidelines on hypothyroidism management recommend levothyroxine sodium tablets as first-line therapy 6. The guidelines note that alternative formulations should be considered when patients demonstrate persistent TSH variability despite adherence and appropriate administration (empty stomach, 30-60 minutes before food, no concurrent medications that impair absorption).

Clinical scenarios where the gel capsule has documented benefit include patients with celiac disease (even when on a gluten-free diet, subclinical enteropathy may impair absorption), patients who have undergone Roux-en-Y gastric bypass or sleeve gastrectomy, patients on chronic proton pump inhibitor therapy who cannot discontinue the PPI, and patients with documented lactose intolerance who experience GI symptoms from standard tablet fillers.

Dr. Francesco Saverio Vita, the lead author of the 2014 study that helped establish the clinical utility of the gel capsule formulation, concluded that "the soft gel capsule formulation of L-T4 circumvents the absorption impairment caused by gastrointestinal conditions affecting the bioavailability of the tablet form" 1. A subsequent 2015 study published in Endocrine demonstrated that patients switched from tablets to gel capsules achieved target TSH within 8 weeks without dose modification in 85% of cases with documented malabsorption 7.

The American Association of Clinical Endocrinologists (AACE) 2023 update on thyroid disease management notes that "clinicians should be aware of available formulation options including gel capsules and oral solutions for patients with absorption challenges" 8.

What to Ask Your Prescriber

If you're considering Tirosint in Minnesota, bring your most recent TSH and free T4 results (drawn within the past 6-8 weeks) to your appointment or telehealth visit. Ask specifically whether your insurance plan's PA criteria require a documented trial-and-fail on generic tablets, and if so, whether your medical record already contains that documentation. For Minnesota Medicaid patients, ask your prescriber to submit the PA proactively rather than waiting for a pharmacy rejection, as proactive submission typically results in faster approval.

If cost is the primary barrier, ask about compounded levothyroxine from a Minnesota-licensed 503A pharmacy as an intermediate option. The per-month savings of $170-$200 compared to branded Tirosint may be clinically acceptable if your prescriber monitors TSH closely during the first 8-12 weeks after switching to a compounded formulation, with labs drawn at 6 weeks and 12 weeks to confirm stable absorption.